A developing story.
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions
The move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
www.nbcnews.com